DIFFERENT PATTERNS OF HLA-DR ANTIGEN EXPRESSION IN NORMAL EPITHELIUM, HYPERPLASTIC AND NEOPLASTIC MALIGNANT LESIONS OF THE BREAST

被引:28
作者
CONCHA, A
RUIZCABELLO, F
CABRERA, T
NOGALES, F
COLLADO, A
GARRIDO, F
机构
[1] GEN HOSP BAZA,DEPT ANAT PATHOL,GRANADA,SPAIN
[2] UNIV GRANADA,HOSP VIRGEN NIEVES,DEPT CLIN ANAL & IMMUNOL,GRANADA,SPAIN
[3] UNIV GRANADA,HOSP VIRGEN NIEVES,RES UNIT,GRANADA,SPAIN
[4] CLIN HOSP GRANADA,DEPT PATHOL ANAT,GRANADA,SPAIN
来源
EUROPEAN JOURNAL OF IMMUNOGENETICS | 1995年 / 22卷 / 04期
关键词
D O I
10.1111/j.1744-313X.1995.tb00246.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fifteen samples of non-tumoural breast tissue, 24 cases of benign lesions, four biopsies of inflammatory carcinomas and 94 tumour samples of primitive mammary carcinomas were analysed for HLA class II expression. We found, first, that HLA class II antigens were detectable in all cases of non-neoplastic breast tissue. Secondly, HLA class II antigen expression was notably increased in benign neoplasms and hyperplastic lesions. In contrast, only 32 out of 94 carcinomas showed expression of HLA-DR antigens, 17 tumours had HLA-DP antigens and 11 carcinomas were positive for the presence of DQ molecules. The expression of class II antigen was associated with the degree of histological differentiation (P < 0.05) but was independent of stromal leucocytic infiltration. Thirdly, HLA-DR was very strongly expressed in intravascular tumoural thrombi, especially in the 'inflammatory carcinomas'. The immunephenotype of inflammatory infiltrate was analysed in benign and malignant lesions. In malignant lesions the mean number of inflammatory cells was significantly higher than in benign lesions. Interestingly, we found no differences in the amount and composition of inflammatory infiltrate between HLA-DR positive and negative tumours.
引用
收藏
页码:299 / 310
页数:12
相关论文
共 44 条
[1]  
ACOLLA RS, 1991, INT J CANC S, V6, P20
[2]  
ALEXANDER MA, 1989, J IMMUNOL, V142, P4070
[3]  
AN T, 1987, AM J PATHOL, V128, P52
[4]   STRONG HLA-DR EXPRESSION IN LARGE-BOWEL CARCINOMAS IS ASSOCIATED WITH GOOD PROGNOSIS [J].
ANDERSEN, SN ;
ROGNUM, TO ;
LUND, E ;
MELING, GI ;
HAUGE, S .
BRITISH JOURNAL OF CANCER, 1993, 68 (01) :80-85
[5]   EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS AND CHARACTERIZATION OF THE LYMPHOCYTE INFILTRATE IN HYPERPLASTIC POLYPS OF THE LARGE-BOWEL [J].
BEDOSSA, P ;
POYNARD, T ;
BACCI, J ;
NAVEAU, S ;
LEMAIGRE, G ;
CHAPUT, JC ;
MARTIN, E .
HUMAN PATHOLOGY, 1990, 21 (03) :319-324
[6]  
BOTAZZO GF, 1983, LANCET, V1, P115
[7]   PHENOTYPIC DYNAMICS OF TUMOR PROGRESSION IN HUMAN-MALIGNANT MELANOMA [J].
BROCKER, EB ;
SUTER, L ;
BRUGGEN, J ;
RUITER, DJ ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (01) :29-35
[8]  
BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707
[9]  
CABRERA T, 1986, HYBRIDOMA, V5, P440
[10]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229